| alpha-MaleiMidopropionyl-oMega-succiniMidyl-6(ethylene glycol) |
Α-MALEIMIDOPROPIONYL-Ω-SUCCINIMIDYL-6(ETHYLENE GLYCOL) |
1137109-21-7 |
| alpha-MaleiMidopropionyl-oMega-succiniMidyl-10(ethylene glycol) |
Α-MALEIMIDOPROPIONYL-Ω-SUCCINIMIDYL-10(ETHYLENE GLYCOL) |
1137109-22-8 |
| URMC-099 |
URMC-099 |
1229582-33-5 |
| Thiazovivin |
THIAZOVIVIN |
1226056-71-8 |
| 2-(2-Chlorophenyl)-4-(3-(diMethylaMino)phenyl)-5-Methyl-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione |
2-(2-氯苯基)-4-[3-(二甲基氨基)苯基]-5-甲基-1H-吡唑并[4,3-C]吡啶-3,6(2H,5H)-二酮 |
1218942-37-0 |
| MPEG7-CH2CH2COOH |
4,7,10,13,16,19,22,25-八氧杂二十六烷酸 |
1093647-41-6 |
| GSK-2126458 |
GSK2126458 |
1086062-66-9 |
| AP26113 |
AP26113 |
1197958-12-5 |
| FMoc-NH-PEG9-CH2CH2COOH |
5,8,11,14,17,20,23,26,29-九氧杂-2-氮杂三十二碳二酸 1-(9H-芴-9-基甲基)酯 |
1191064-81-9 |
| Baricitinib |
巴瑞克替尼 |
1187594-09-7 |
| Cabozantinib Malate |
苹果酸卡博替尼 |
1140909-48-3 |
| FMOC-TYR(PO(OBZL)OH)-OH |
N-芴甲氧羰基-O-苄基-L-磷酸酪氨酸 |
191348-16-0 |
| O-(2-AMinoethyl)-O'-[2-(Boc-aMino)ethyl]tetraethylene Glycol |
O-(2-氨基乙基)-O'-[2-(叔丁氧羰基-氨基)乙基]四乙二醇 |
189209-27-6 |
| FMOC-VAL-SER(PSIME,MEPRO)-OH |
(4S)-3-[(2S)-2-[[芴甲氧羰基]氨基]-3-甲基-1-氧代丁基]-2,2-二甲基-4-恶唑烷羧酸 |
186023-49-4 |
| H2N-PEG4-Propyne |
1-氨基-3,6,9,12-四氧十五烷-14-炔 |
1013921-36-2 |
| (4S,5R)-3-tert-butoxycarbony-2-(4-anisy)-4-phenyl-5-oxazolidinecarboxylic acid |
(4S,5R)-2-(4-甲氧基苯基)-4-苯基-3,5-恶唑烷二羧酸 3-叔丁酯 |
196404-55-4 |
| [2-[2-(Fmoc-amino)ethoxy]ethoxy]acetic acid |
[2-[2-(Fmoc-氨基)乙氧基]乙氧基]乙酸 |
166108-71-0 |
| (S)-tert-butyl 2-((1R,2R)-3-(((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidine-1-carboxylate |
BOC-DAP-NE |
160800-65-7 |
| 2,5,8,11,14,17,20-Heptaoxadocosan-22-amine |
2,5,8,11,14,17,20-七氧杂二十二烷-22-胺 |
170572-38-0 |
| LY 294002 HYDROCHLORIDE |
LY294002/PI3K抑制剂 |
154447-36-6 |
